CSI Market
Sign In | Register

Inhibitor Therapeutics Inc (HPPI) Annual Balance Sheets

Annual · GAAP · USD millions
Access HPPI quarterly Balance Sheets →
Tracking balance sheet results across Inhibitor Therapeutics Inc to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.38
Cash & Short-term Investments2.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.07
Total Current Assets2.45
Other Assets, Noncurrent0.06
Operating Lease Right Of Use Asset0.06
Total Assets2.51
Liabilities
Accounts Payable, Current AC0.05
Accrued Liabilities, Current AC0.69
Long-term Debt and Capital Lease Obligations, Current DE0.02
Other Liabilities, Current0.00
Total Current Liabilities0.77
Long-term debt0.04
Total Long-term Debt0.04
Deferred Revenue, Noncurrent DE3.00
Other liabilities, Noncurrent0.00
Total Liabilities3.80
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock54.11
Retained Earnings / Accumulated Deficit-55.42
Other Equity0.00
Common Stockholder's Equity-1.29
Total Stockholder's Equity-1.29
Liabilities & Stockholder's Equity2.51
4 historic quarters locked

Sign in to unlock the full Inhibitor Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Inhibitor Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 25, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-012751

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License